Sonoma Pharmaceuticals (SNOA) Tops Q1 EPS by 21c

Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q1 EPS of ($0.09), $0.21 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $4.99 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
• RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)